Barely Significant
← all excerpts

Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial.

Cancer Med · 2023 · PMC10652346 · PMID 37814921

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

a decreasing trendp > 0.05actually significant
Although there was no statistically significant difference, both groups showed a decreasing trend in AFP at the first follow‐up compared to baseline ( p > 0.05; Table 3 ). 3.4.

also in 44,411 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.